Day: August 6, 2025

GLP-1 receptor agonists (GLP-1 RA) are a class of medications originally developed to treat type 2 diabetes, but have since gained widespread attention for their effects on weight loss and metabolic health. These drugs work by mimicking a natural hormone called GLP-1 (glucagon-like peptide-1), which helps regulate blood sugar, appetite, and digestion.
Emerging research suggests that GLP1-Receptor Agonists could be supportive in managing inflammatory symptoms associated with Mast Cell Activation Syndrome (MCAS). Although research is currently limited, this is what we know so far.